Bicocca Open Archive

Logo unimib boa
DELL'ORO, RAFFAELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.100
AS - Asia 9.951
EU - Europa 6.331
SA - Sud America 1.444
AF - Africa 252
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 9
Totale 32.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.786
SG - Singapore 3.615
CN - Cina 2.065
VN - Vietnam 1.602
HK - Hong Kong 1.278
RU - Federazione Russa 1.198
BR - Brasile 1.119
IT - Italia 963
DE - Germania 926
SE - Svezia 864
IE - Irlanda 641
UA - Ucraina 402
GB - Regno Unito 345
FR - Francia 314
IN - India 283
KR - Corea 207
CA - Canada 196
FI - Finlandia 175
BD - Bangladesh 140
AT - Austria 123
AR - Argentina 110
IQ - Iraq 109
ID - Indonesia 92
TR - Turchia 87
ZA - Sudafrica 86
PK - Pakistan 74
MX - Messico 71
JP - Giappone 61
PL - Polonia 61
NL - Olanda 60
SA - Arabia Saudita 54
EC - Ecuador 52
PH - Filippine 49
ES - Italia 46
CO - Colombia 44
UZ - Uzbekistan 43
VE - Venezuela 42
DK - Danimarca 40
KE - Kenya 31
BE - Belgio 29
MY - Malesia 28
TN - Tunisia 26
AU - Australia 25
CL - Cile 25
MA - Marocco 23
PY - Paraguay 21
CZ - Repubblica Ceca 20
EG - Egitto 20
JO - Giordania 19
AE - Emirati Arabi Uniti 16
ET - Etiopia 16
PE - Perù 15
BG - Bulgaria 14
LT - Lituania 14
RO - Romania 14
AZ - Azerbaigian 12
CH - Svizzera 11
AL - Albania 10
IR - Iran 10
KZ - Kazakistan 10
LB - Libano 10
DZ - Algeria 9
LK - Sri Lanka 9
PS - Palestinian Territory 9
BY - Bielorussia 8
EE - Estonia 8
HN - Honduras 8
IL - Israele 8
JM - Giamaica 8
PT - Portogallo 8
TH - Thailandia 8
UY - Uruguay 8
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
EU - Europa 7
NP - Nepal 7
OM - Oman 7
BH - Bahrain 6
BO - Bolivia 6
PA - Panama 6
QA - Qatar 6
RS - Serbia 6
SN - Senegal 6
AO - Angola 5
CR - Costa Rica 5
HR - Croazia 5
HU - Ungheria 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
GR - Grecia 4
NG - Nigeria 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BB - Barbados 3
GE - Georgia 3
KG - Kirghizistan 3
MG - Madagascar 3
MK - Macedonia 3
MU - Mauritius 3
Totale 32.070
Salva come PNG Salva come JPEG
Città #
Singapore 2.013
Ann Arbor 1.870
Ashburn 1.338
Hong Kong 1.255
San Jose 945
Fairfield 898
Woodbridge 884
Houston 627
Dublin 614
Chandler 587
Frankfurt am Main 569
Wilmington 470
Ho Chi Minh City 438
Hefei 405
Jacksonville 404
Hanoi 403
New York 374
Seattle 351
Dallas 322
Beijing 317
Milan 278
Chicago 270
Dearborn 268
Santa Clara 258
Los Angeles 239
Cambridge 235
Princeton 210
Seoul 201
The Dalles 201
Lauterbourg 138
Moscow 128
Nanjing 108
São Paulo 105
Lawrence 104
Shanghai 102
Vienna 102
Buffalo 99
Altamura 94
Da Nang 85
Munich 73
Council Bluffs 67
Helsinki 66
Lachine 63
Haiphong 62
Orem 62
Jakarta 57
San Diego 57
London 54
Guangzhou 53
Chennai 51
Baghdad 49
Lissone 46
Rio de Janeiro 42
Nanchang 41
Warsaw 41
Dong Ket 40
Boardman 38
Rome 37
Johannesburg 36
Tashkent 36
Tokyo 36
Changsha 35
Toronto 35
Montreal 34
Atlanta 33
Andover 32
Turku 32
Düsseldorf 31
Shenyang 31
Brooklyn 30
Hebei 30
Nuremberg 30
Denver 29
Belo Horizonte 28
Tianjin 28
Dhaka 27
Mumbai 27
Salt Lake City 27
San Francisco 27
Fremont 25
Brussels 24
Columbus 24
Falls Church 24
Hải Dương 24
Phoenix 22
Zhengzhou 22
Ha Long 21
Hangzhou 21
Jiaxing 21
Jinan 21
Kunming 21
Poplar 21
Riyadh 21
Can Tho 20
Lahore 19
Monza 19
Nairobi 19
New Delhi 19
Norwalk 19
Ottawa 19
Totale 20.408
Salva come PNG Salva come JPEG
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 463
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 453
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 440
Heart rate as a sympathetic marker during acute adrenergic challenge 421
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 335
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 321
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 321
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 311
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 304
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 294
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 289
Neurogenic abnormalities in masked hypertension 288
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 287
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 282
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 282
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 280
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 278
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 277
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 273
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 271
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 270
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 269
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 266
Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity 263
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 263
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 262
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 261
Threshold and Target for Blood Pressure Lowering in the Elderly 260
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 259
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 259
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 259
Extreme dipping: Always means nocturnal hypotension? 258
Role of ambulatory blood pressure monitoring in resistant hypertension 256
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 253
IMPACT OF SEASONAL BLOOD PRESSURE CHANGES ON VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY 251
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 250
Adrenergic and reflex abnormalities in obesity-related hypertension 248
Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly 246
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 244
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 242
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 240
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 240
Diurnal blood pressure variation and sympathetic activity 239
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 237
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 235
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 234
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 234
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 230
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 229
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 228
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 228
Effects of acute carotid baroreceptor stimulation on sympathetic nerve traffic in resistant and uncontrolled hypertension: a systematic review and meta-analysis 227
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 227
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 226
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 222
Predictive value of different indices of blood pressure variability on 220
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 220
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 220
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 214
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 214
Early sympathetic activation in the initial clinical stages of chronic renal failure 213
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 212
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 212
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 212
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study 204
The "J curve" problem revisited: old and new findings 204
New onset left atrial dilatation in the general population: A quarter-century follow-up 203
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 203
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 203
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 203
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 203
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 202
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 202
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 197
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 196
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 194
Left ventricular hypertrophy in isolated and dual masked hypertension 191
Sympathetic activation in obesity: a noninnocent bystander 190
Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias 189
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 189
Salt intake and sympathetic activity - Response 189
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 188
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome: Is there any role for obstructive sleep apnea? 187
Essential hypertension and the sympathetic nervous system 187
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 187
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 187
How to assess sympathetic nervous system activity in clinical practice 185
Baroreflex activation therapy systems: current status and future prospects 185
Cardio-Ankle Vascular Index As A Marker Of Left Ventricular Hypertrophy In Treated Hypertensives: Findings From The Pamela Study 184
Habitual Regular Coffee Consumption And Arterial Stiffness -Data From The 3rd Pamela Survey 184
Prevalence, Awareness And Treatment Of Cardiovascular Risk Factors In Health Professionals In The Cardiovascular Field: The Protecto Esh-Siia Study 182
Antihypertensive treatment and stroke prevention: From recent meta-analyses to the PRoFESS trial 182
Blood pressure control and antihypertensive treatment 181
Retinal arteriolar narrowing as marker of renal dysfunction: potential value and limitations 181
The neglected role of the electrocardiogram in the diagnostic work-up of hypertensive patients: a study in clinical practice 181
Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH Guidelines 180
Coffee consumption, clinic, 24-hour and home blood pressure. Findings from the PAMELA study 178
Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement 178
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? 178
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients 178
Totale 23.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021308 0 0 0 0 0 0 0 0 0 0 116 192
2021/20221.700 147 125 235 183 138 128 71 68 95 110 163 237
2022/20232.510 270 708 231 253 150 408 41 155 140 34 80 40
2023/20242.062 51 54 89 112 285 491 388 61 224 39 41 227
2024/20255.787 329 665 231 251 467 161 288 280 536 852 710 1.017
2025/202612.624 1.888 1.086 1.158 1.564 1.445 690 1.941 604 1.026 1.191 31 0
Totale 32.704